Form4.ai tracks every SEC insider trade in real time. See every MDCX insider filing with a free account — no card.
See every MDCX insider filing — free account, no card.
Free accountMedicus Pharma Ltd. (MDCX) has 5 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Sept. 8, 2026.
Open-market value, last 90 days
No open-market buys or sales in this period.
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 8, 2026 SEC filing | Smith Andrew Alasdair Chief Operating Officer | Grant / award | $125,368 | — |
| Sep 8, 2026 SEC filing | Mehmud Faisal Chief Medical Officer | Grant / award | $250,735 | — |
| Sep 8, 2026 SEC filing | Brennan Edward J. Chief Scientific Officer | Grant / award | $100,294 | — |
Create a free account to see all 5 MDCX filings from the last 90 days. No card needed.
Create free accountWant MDCX insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.